Ecdysterone and High-Intensity Interval Training Mitigate Alzheimer's Pathology in Rats: Impacts on Depression,...

Area of Science:

• Neuroscience
• Pharmacology
• Exercise Physiology

Background:

• Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) accumulation, leading to neuroinflammation and impaired synaptic plasticity.
• Depression is a common comorbidity in AD, exacerbating cognitive decline.

Purpose of the Study:

• To investigate the therapeutic potential of Ecdysterone and high-intensity interval training (HIIT), alone and in combination, on Aβ-induced Alzheimer's disease progression in a rat model.
• To assess the impact of these interventions on depressive-like behavior, synaptic function, neuroinflammation, and Aβ plaque burden.

Main Methods:

• Rats received Aβ administration followed by 8 weeks of Ecdysterone (10 mg/kg/day) and/or HIIT.
• Behavioral tests (forced swim test), electrophysiological recordings (long-term potentiation), Congo red staining for Aβ plaques, and quantification of neuroinflammatory markers were employed.

Main Results:

• Aβ administration induced depression-like behavior, synaptic dysfunction, inflammation, and Aβ accumulation.
• Both Ecdysterone and HIIT individually provided partial protection.
• The combination of Ecdysterone and HIIT demonstrated significantly greater efficacy in improving depressive behavior, restoring synaptic function, reducing neuroinflammation, and decreasing Aβ burden in the hippocampus and cerebral cortex.

Conclusions:

• Combined Ecdysterone and HIIT treatment offers a potent therapeutic strategy for mitigating Aβ-induced Alzheimer's disease pathology and associated depressive-like behavior.
• The synergistic effects may stem from improved synaptic function, reduced neuroinflammation, and suppressed Aβ plaque formation.